Enhancing Transfection Efficacy in Glioma Cells: A Comparison of Microfluidic versus Manual Polypropylenimine Dendriplex Formation
Open Access
- 1 November 2024
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 12189-12203
Abstract
Background: Gene therapy is a promising therapeutic approach for treating various disorders by introducing modified nucleic acids to correct cellular dysfunctions or introduce new functions. Despite significant advancements in the field, the effective delivery of nucleic acids remains a challenge, due to biological barriers and the immune system’s ability to target and destroy these molecules. Due to their branched structure and ability to condense negatively charged nucleic acids, cationic dendrimers have shown potential in overcoming these challenges. Despite this, standardized scalable production methods are still lacking. This study investigates the use of microfluidics to formulate generation 3-diaminobutyric polypropylenimine (DAB) dendriplexes and compares their characteristics and in vitro gene delivery efficacy to those prepared using conventional manual mixing. Methods: DAB dendriplexes were produced by both microfluidic and manual approaches and characterized. Their cellular uptake and gene expression were evaluated on C6 glioma cancer cells in vitro. Results: Dendriplexes formed using microfluidics at the optimal flow rate and ratio demonstrated enhanced DNA condensation over time, achieving up to 97% condensation at 24 hours. Both preparation methods produced positively charged dendriplexes, indicating stable formulations. However, dendriplexes prepared through hand mixing resulted in smaller particle sizes, significantly higher cellular uptake and gene expression efficacy compared to those prepared by microfluidics. Nonetheless, microfluidic preparation offers the advantage of standardized and scalable production, which is essential for future applications. Conclusion: This study highlights the potential of microfluidic technology to improve precision and scalability in gene delivery, paving the way for future advancements in gene therapy. Our findings suggest that, with further optimization, microfluidic systems could provide superior control over dendriplex formation, expanding their potential use in gene therapy applications.Keywords
This publication has 35 references indexed in Scilit:
- Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applicationsNanoscale Advances, 2021
- Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and ProspectsThe AAPS Journal, 2021
- Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cellsBiomaterials Science, 2020
- Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09bPharmaceutics, 2020
- Manufacturing Considerations for the Development of Lipid Nanoparticles Using MicrofluidicsPharmaceutics, 2020
- Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12Drug Delivery, 2018
- Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray dryingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2017
- Microfluidics-mediated assembly of functional nanoparticles for cancer-related pharmaceutical applicationsNanoscale, 2016
- Synthetic Anticancer Gene Medicine Exploits Intrinsic Antitumor Activity of Cationic Vector to Cure Established TumorsCancer Research, 2005
- The Lower-Generation Polypropylenimine Dendrimers Are Effective Gene-Transfer AgentsPharmaceutical Research, 2002